¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Enduring personality change after psychiatric illness"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® antisocial personality disorder ÇÑ±Û ¹Ý»çȸÀûÀΰÝÀå¾Ö
¼³¸í   
  Áö¼ÓÀûÀ¸·Î ±×¸®°í ¸¸¼ºÀûÀ¸·Î ¹Ý»çȸÀûÀΠÇൿÀ» Çϴ Á¤½Å°úÀû º´. ´Ù¸¥ »ç¶÷¿¡°Ô Áø½Ç¼ºÀÌ ¾ø°í ´Ù¸¥ »ç¶÷ÀÇ ±Ç¸®³ª ÇÇÇØ¿¡´Â ÀüÇô ¹«°¨°¢Ç졒ʫÜÁö ÀÚ½ÅÀÇ Ãæµ¿°ú ¿å±¸¿¡ ÀÇÇØ¼­ ÇൿÀ» ÇÑ´Ù. ÀÚ½ÅÀÇ ½Ç¼ö¿¡ ´ëÇØ¼­ ´Ù¸¥ »ç¶÷ÀÌ Ãæ°íÇϴ °ÍÀ» ÂüÁö¸øÇϰí Ç×»ó ÀÚ½ÅÀÇ ¸¶À½´ë·Î¸¸ ÇÑ´Ù.
¿µ¹® personality ÇÑ±Û ÀΰÝ
¼³¸í   
  ÇÑ »ç¶÷ÀÌ »ý°¢Ç졒ʫÀ³¢°í ÇൿÇϴ Ư¡µéÀ» ¸»Çϸ砺ñ±³Àû ¾ÈÁ¤µÇ°í ¿¹ÃøÇÒ ¸¸ÇÑ ±× »ç¶÷ÀÇ »ç°í³ª ÇൿÀ» ÁöĪÇÑ´Ù. À̴ ¶ÇÇÑ ÀǽÄÀûÀΠŵµ, °¡Ä¡°ü ¹× ¾ç½Ä°ú ¹«ÀǽÄÀûÀΠ°¥µî ¹× ¹æ¾î¸ÞÄ¿´ÏÁòÀ» Æ÷ÇÔÇÑ´Ù. ÀÎ°ÝÆ¯¼ºÀ̶õ ±× Ç¥Çö¹æ½ÄÀÌ º´ÀûÀ̶ó°í »ý°¢µÇÁö ¾Ê´Â »ç¶÷ÀÌ ÇൿÇ졒ʫÀ³¢°í »ý°¢Çϴ ÁֵȠ¼ºÇâÀ» ¸»ÇÑ´Ù. ÀΰÝÀå¾Ö¶õ À¶Å뼺ÀÌ ¾ø°í ºñÀûÀÀ¼º ÀÎ°ÝÆ¯¼ºÀ¸·Î ÀÌ·ç¾îÁø Æ¯¼öÇÑ Á¤½ÅÀå¾Ö¸¦ ÀÚÁÖ ¹üÇϰԠµÇ°í, ÁÖ°üÀûÀΠ°íÅëÀ» °¡Á®¿À°Ô µÇ¸ç °á±¹ »çȸÀû ±â´É¿¡ Å« Àå¾Ö¸¦ ÃÊ·¡Çϴ °ÍÀÌ´Ù.
¿µ¹® personality disorder ÇÑ±Û ÀΰÝÀå¾Ö, ¼º°ÝÀå¾Ö
¼³¸í   
  Å¸°í³­ Àμº°ú ¼ºÀå°úÁ¤ÀÇ ¿©·¯ »ç°Ç, ±×¸®°í ±³À°Á¤µµ¿¡ µû¶ó °³ÀÎÀÇ ÀΰÝÀº Çü¼ºµÈ´Ù. ÀÌ·± ÀΰÝ(¼º°Ý)ÀÌ »çȸ»ýȰ, È¤Àº °¡Á·»ýȰ¿¡ ÁöÀåÀ» Áְųª, ÀÚ±âÀÚ½ÅÀÇ »ýȰ¿¡ ÇÇÇØ¸¦ Áִ °æ¿ì, À̸¦ ÀΰÝÀå¾Ö¶ó ºÎ¸¥´Ù. ½ÇÁ¦·Î ÀÌ·± ÀÏ·ÃÀÇ ¼º°ÝµéÀº ´©±¸³ª Á¤»óÀûÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖÀ¸³ª, À̻󼺰ÝÀÌ ½ÉÇÑ °æ¿ì Ä¡·áÀÇ ´ë»óÀÌ µÈ´Ù.
¿µ¹® narcissistic personality disorder ÇÑ±Û ÀÚ±â¾ÖÀû ÀΰÝÀå¾Ö
¼³¸í   
  ÀÚ½ÅÀÇ Á߿伺°ú µ¶Æ¯ÇÔ, À¯ÀÏÇÔ¿¡ ´ëÇÑ ±¤ÀûÀΠÁýÂø°ú ÀÚ½ÅÀÌ ¼º°øÇÒ °ÍÀ̶ó´Â Áö³ªÄ£ ÁýÂøÀ» º¸¿©Áִ ¼º°ÝÀå¾Ö. Áö³ªÄ£ Àڱ⿡ÀÇ ¸¸Á·°¨À» °¡Áö°í, Áö³ªÄ£ Àڽۨ, ¼º°ø¿¡ ´ëÇÑ È®½ÅÀ» Áö´Ï°í ÀÖ´Ù.
¿µ¹® histrionic personality disorder ÇÑ±Û È÷½ºÅ׸®ÀΰÝÀå¾Ö
¼³¸í   
  Áö³ªÄ¡°Ô ¿¬±ØÀûÀÌ°í ¹ÝÀÀÀûÀ̸ç ÇൿÀÇ Áö³ªÄ£ Ç¥Çö ¹× Æ¯À¯ÇÑ ´ëÀΰü°èÀÇ Àå¾Ö¸¦ ÁַΠÇϴ Á¤½Åº´. È÷½ºÅ׸®ÀΰÝÀå¾Ö´Â ¿ÜºÎ¿¡ ´ëÇÑ ¹ÝÀÀÀÌ Áö³ªÄ¡°Ô ºü¸£°í Àڱ⸦ °ú½ÃÇ졒ʫëÀΰü°è¿¡¼­ ÇÇ»óÀûÀÌ°í ºÒ¼º½ÇÇØ¼­ ´ëÀΰü°è¿¡ Àå¾Ö°¡ Àִ À̻󼺰ÝÀ¸·Î¼­ ¼º½É¸®°¡ ¹Ì¼÷ÇÑ °ÍÀ̠Ư¡ÀÌ´Ù. ¾ðÁ¦³ª ÀÚ½ÅÀ» ¸ÚÁö°Ô µå·¯³» º¸ÀÌ·Á ÇÏ°í ´Ù¸¥ »ç¶÷ÀÇ °ü½ÉÀ» ²ø±â À§ÇØ °úÀåµÈ Ç¥ÇöÀ» ÇÑ´Ù. ¾Æ´Â »ç¶÷À» ¸¸³ª¸é Áö³ªÄ¥ Á¤µµ·Î ¹Ý°¡¿öÇÏ°í ¸¶Ä¡ °øÁÖ³ª ¿ÕÀÚ°°Àº Ç༼¸¦ Çϴ ¼ö°¡ ÀÖ´Ù. ÀÛÀº Àڱؿ¡µµ ½±°Ô ÈïºÐÇϰí È­¸¦ Àß ³»³ª ÀÛÀº ±â»Ý¿¡ Áö³ªÄ¡°Ô ¹ÝÀÀÇϴ º¯´ö½º·¯¿î ¼º°ÝÀÇ ¼ÒÀ¯ÀÚÀÌ´Ù. ³í¸®ÀûÀΠ°Íº¸´Ù´Â °¨Á¤ÀûÀ¸·Î ÀÏÀ» Ã³¸®Ç졒ʫëÀΰü°è¿¡¼­ »ó´ë¹æÀÇ Àǻ縦 ÀÚ±â È¯»ó¿¡ µû¶ó ¸Ú´ë·Î Çؼ®ÇÑ´Ù. ºÒ¸¸½º·¯¿î ÀÏÀÌ ÀÖÀ¸¸é ÀÚ»ìÇÑ´Ù°í À§ÇùÇϰųª ÀÚ»ìÀÇ ¿¬±ØÀ» ²Ù¸ç¼­ »ó´ë¹æÀ» Á¶Á¤ÇÑ´Ù. Ç¥¸éÀûÀ¸·Î´Â °¨Á¤À̠dzºÎÇÏ°í ¸Å·ÂÀûÀÌ°í »ç±Í±â ½±Áö¸¸ ´ëÀΰü°è¿¡¼­ Áö¼Ó¼ºÀÌ ¾ø°í ½±°Ô »ç±Í¾ú´Ù°¡ ½±°Ô Çì¾îÁö°í ±³Á¦Çϴ »ç¶÷Àº ¸¹À¸³ª »ó´ë°¡ ÀÚÁÖ ¹Ù²ï´Ù. Çѹø »ç±Í°Ô µÇ¸é »ó´ë¹æÀÇ ÀÇ»ç´Â ¾Æ¶û°÷ÇÏÁö ¾Ê°í Àڱ⠿䱸¸¸ µé¾îÁֱ⸦ ¹Ù¶ó´Â À̱âÀûÀΠ»ç¶÷ÀÌ°í ±×°ÍÀÌ ÃæÁ·µÇÁö ¸øÇϸ頰ð ½Ç¸ÁÇÏ°í ±× »ç¶÷À» ¿ø¸ÁÇÑ´Ù. ¼ºÀû ÀûÀÀ·Âµµ Èñ¹ÚÇÏ¿© ¼ºÀûÀ¸·Î ¸Å·ÂÀÌ À־¸ÀÌ°í ¾Ö±³°¡ ÀÖ°í ¼ºÀû ºÐÀ§±â¸¦ ¹°¾À Ç³±âÁö¸¸ ºÒ°¨ÁõÀΠ°æ¿ì°¡ ¸¹´Ù. À̼º°ü°è¸¦ ³¶¸¸ÀûÀΠȯ»óÀ¸·Î ²ø°í °¡·Á°í ÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mental illness
    Á¤½ÅÁúȯ
  • antisocial personality
    ¹Ý»çȸÀûÀΰÝ
  • antisocial personality disorder
    ¹Ý»çȸÀûÀΰÝÀå¾Ö
  • anxious and fearful personality
    ºÒ¾È°øÆ÷ÀΰÝ
  • anxious personality disorder
    ºÒ¾ÈÀΰÝÀå¾Ö
  • apathetic personality
    ¹«°¨µ¿ÀΰÝ
  • as-if personality
    °¡ÀåÀΰÝ
  • asocial personality disorder
    ºñ»çȸÀûÀΰÝÀå¾Ö
  • authoritarian personality
    ±ÇÀ§Àû¼º°Ý
  • avoidant personality disorder
    ȸÇÇÀΰÝÀå¾Ö
  • aggressive personality
    °ø°ÝÀûÀΰÝ
  • alternating personality
    ±³´ëÀΰÝ
  • amoral personality
    ºñµµ´öÀΰÝ
  • anal personality
    Ç×¹®±âÀΰÝ
  • anankastic personality
    °­¹ÚÀΰÝ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • illness
    Áúº´
  • long v illness
    Àå±âÁúȯ
  • mental illness
    Á¤½ÅÁúȯ
  • mountain illness
    °í»êº´
  • protracted illness
    Áö¿¬Áúº´
  • recent illness
    ÃÖ±ÙÀÌȯ
  • aggressive personality
    °ø°ÝÀΰÝ
  • alternating personality
    ±³´ë¼ºÀΰÝ
  • amoral personality
    ºñµµ´öÀΰÝÀå¾Ö
  • anal personality
    Ç×¹®±âÀΰÝ
  • anankastic personality
    (¢¡obsessive-compulsive personality) °­¹ÚÀΰÝ
  • anankastic personality disorder
    °­¹ÚÀΰÝÀå¾Ö
  • antisocial personality
    ¹Ý»çȸÀΰÝ
  • antisocial personality disorder
    ¹Ý»çȸÀΰÝÀå¾Ö
  • anxious and fearful personality
    ºÒ¾È°øÆ÷ÀΰÝ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • psychiatric interview
    Á¤½ÅÀÇÇÐÀû ¸é´ã
  • psychiatric service
    Á¤½Å°ú ÀÇ·á
  • Decompression illness
    °¨¾Ðº´
  • acute illness policy
    ±Þ¼ºÁúȯÁ¤Ã¥<--¹æÄ§>
  • acute respiratory illness =ARI
    ±Þ¼º È£Èí±âº´.
  • acute respiratory illness =ARI
    ±Þ¼º È£Èí±âº´.
  • high-altitude illness
    °í¼Ò¼ºÁúº´
  • illness
    Áúº´(̤ËÓ).
  • illness behavior
    Áúº´ÇàÅÂ.
  • illness phobia
    Áúº´ °øÆ÷Áõ(º´)
  • recurring illness
    ȸ±Í¼º Áúȯ.
  • recurring illness
    ȸ±Í¼º Áúȯ(üÞÏýàõòðü´)
  • after action
    ÈÄ(¼Ó)(ý­(áÙ))ÀÛ¿ë.
  • after care
    ÈÄÄ¡·á(ý­ö½èþ), Èĺ¸È£(ý­ÜÁûÞ), ȸº¹±âÄ¡·á, ȸº¹±âº¸È£.
  • after cataract
    ÈĹ߹鳻Àå.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • after load
    ÈĺÎÇÏ(ý­Ý¶ùÃ).
  • after-depolarization
    ÈÄÅ»ºÐ±Ø(ý­÷­ÝÂп)
  • after-discharge
    ÈĹ߻ç(ý­Û¡ÞÒ) ¹Ý»çÀÇ
  • after-load
    ÈĺÎÇÏ(ý­Ý¶ùÃ)
  • after-movement
    ÈĿ(Ì·ËôËÄ).
  • after-nystagmus
    ÈĹ߾ÈÁø
  • after-pain
    ÈÄÁøÅë(ý­òæ÷Ô).
  • after-vision
    ÀÜ»ó½Ã°¢(íÑßÀò±ÊÆ).
  • nystagmus, optokinetic after [=OKAN]
    ½Ã¿îµ¿(¼º) ÈľÈÁø
  • optokinetic after nystagmus =OKAN
    ½Ã¼±À̵¿¼º ÈľÈÁø.
  • optokinetic after nystagmus =OKAN
    ½Ã¼±À̵¿¼º ÈľÈÁø.
  • optokinetic after nystagmus [=OKAN]
    ½Ã¿îµ¿¼ºÈľÈÁø
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
  • acute illness policy
    ±Þ¼ºÁúȯÁ¤Ã¥<--¹æÄ§>
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BPRS brief psychiatric rating scale; brief psychiatric reacting scale
NPI Narcissistic Personality Inventory; neuropsychiatric institution; no present illness; nucleoplasmic ...
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
SPD schizotypal personality disorder; sociopathic personality disorder; specific paroxysmal discharge; s...
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PES Psychiatric Emergency Service
CGI-C Clinical Global Impression of Change
FAC Fractional area change
HSC Health System Change
MCD Minimal change disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • after dribbling
    ÈÄÀÓÀû
  • after image
    ˆȗ
    ½Ã°¢ÀÇ ¿¹¹Î¼ºÀ¸·Î ÀÎÇØ ¿ÜºÎ·ÎºÎÅÍÀÇ ÀÚ±ØÀÌ »ç¶óÁø ÈÄ¿¡µµ ³²¾ÆÀÖ´Â ÈïºÐÀ¸·Î ÀÎÇØ ½Ã ÀÚ±ØÀÌ ¿¬ÀåµÇ°Å³ª »õ·Î¿öÁö´Â ´À³¦.
  • after load
    ÈÄ ºÎÇÏ
  • after-care
    ÈÄ Ä¡·á, ÈÄ º¸È£, ȸº¹±â Ä¡·á, ȸº¹±â º¸È£
    º´À̳ª ¼ö¼ú ÈÄÀÇ µÞÁ¶¸®. ȸº¹±âÀÇ È¯ÀÚ, ƯÈ÷ ¼ö¼úÀ» ¹ÞÀº ȯÀÚÀÇ °£È£¿Í Ä¡·á.
  • after-discharge
    ÈÄ¹ß»ç ¹Ý»çÀÇ
    ÀÚ±ØÀÌ ³¡³­ µÚ¿¡µµ ÀÓÆÞ½ºÀÇ ¹ß»ýÀÌ Áö¼ÓµÇ´Â °Í.
  • after-load
    ÈÄ ºÎÇÏ
    ½É±Ù ¼öÃà Áß¿¡ ½É±Ù¿¡ °É·Á ÀÖ´Â ºÎÇÏ·®¿¡¼­ ÀüºÎÇÏ·®À» »« ¾çÀÌ´Ù.
  • after-nystagmus
    ÈÄ¹ß ¾ÈÁø
  • after-potential
    ÈÄ ÀüÀ§ Çö»ó
    ½ºÆÄÀÌÅ© ÀüÀ§ µÚ¿¡ º¼ ¼ö ÀÖ´Â ÀüÀ§ º¯µ¿ÀÌ´Ù. À½¼º ÈÄ ÀüÀ§¿Í ¾ç¼º ÈÄ ÀüÀ§·Î ³ª´¶´Ù. ÀüÀÚ´Â ¿ªÄ¡ÀÇ »ó½Â, ÈÄÀÚ´Â Çϰ­À» ÀÏÀ¸Å²´Ù.
  • after-sensation
    ÈÄ °¨°¢
    ¿øÀÎÀÌ µÇ¾ú´ø ÀÚ±ØÀÌ Á¦°ÅµÈ ÈÄ¿¡µµ °è¼ÓµÇ´Â Áö°¢.
  • after-vision
    ÀÜ»ó ½Ã°¢
    ÀÚ±ØÀÌ ±×Ä£ ÈÄ¿¡ ³²¾ÆÀÖ´Â ½Ã°¢ÀÇ ÀÜÁ¸.
  • optokinetic after nystagmus
    ½Ã ¿îµ¿ ÈÄ ¾ÈÁø, ½Ã ¿îµ¿¼º ÈÄ ¾ÈÁø
  • positive after potential
    ¾ç¼º ÈÄÀüÀ§
  • soon after birth
    Ãâ»ý Á÷ÈÄ
  • acromegalic personality
    ¼±´Ü °Å´ë¼º ÀΰÝ
  • affective personality
    Á¤µ¿¼º ÀΰÝ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
hospitals, psychiatric Special hospitals which provide care to the mentally ill patient.
(12 Dec 1998)
social work, psychiatric Use of all social work processes in the treatment of patients in a psychiatric or mental health setting.
(12 Dec 1998)
insurance, psychiatric Insurance providing benefits to cover part or all of the psychiatric care.
(12 Dec 1998)
emergency services, psychiatric Organised services to provide immediate psychiatric care to patients with acute psychological disturbances.
(12 Dec 1998)
Armanni-Ebstein change Glycogen vacuolization of the loops of Henle, seen in diabetics before the introduction of insulin.
Synonym: Armanni-Ebstein change.
(05 Mar 2000)
Baggenstoss change Distention of pancreatic acini by proteinaceous secretion, seen in dehydration.
(05 Mar 2000)
change An alteration; in pathology, structural alteration of which the cause and significance is uncertain.
Synonym: shift.
(05 Mar 2000)
change of life Colloquialism for menopause, climacteric.
(05 Mar 2000)
chemical change A process in which one or more substances are changed into one or more different substances.
(09 Oct 1997)
minimal-change disease <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
minimal-change nephrotic syndrome <nephrology> A disorder of the kidneys which largely affects the glomerulus, the blood filtering structure.
This disorder is one common cause of nephrotic syndrome, minimal glomerular changes, in children affecting 2 to 3 children per 100,000 population under age 16 in the USA. Minimal change disease is also seen rarely in adults. The cause is unknown but may be related to an autoimmune illness.
It is marked by oedema, albuminuria, and an increase in cholesterol in the blood, but otherwise with fairly good renal function. Tubular epithelium is vacuolated by cholesterol droplets, but the glomeruli show only that the foot processes of the glomerular epithelial cells are fused, probably secondary to the proteinuria; the cause of the increased glomerular permeability to plasma protein is unknown.
Risk factors include a history for a immune disorder, recent immunisation or a bee sting.
Diagnosis is made by renal biopsy.
Treatment include systemic corticosteroids which are usually quite effective in curing this disease. Other medications include chlorambucil and cyclophosphamide. In most cases, a moderate protein diet (1 gram protein per Kg body weight per day) will be recommended. Salt (sodium) restriction can be helpful to reduce swelling and vitamin D is usually supplemented.
Synonym: lipoid nephrosis
(27 Sep 1997)
conformational change <cell biology> Alteration in the shape usually the tertiary structure of a protein as a result of alteration in the environment pH, temperature, ionic strength) or the binding of a ligand (to a receptor) or binding of substrate (to an enzyme).
(18 Nov 1997)
Crooke's hyaline change Replacement of cytoplasmic granules of basophil cells of the anterior pituitary by homogenous hyaline material; a characteristic finding in Cushing's syndrome, but usually not present in the cells of a basophil adenoma.
Synonym: Crooke's hyaline degeneration.
(05 Mar 2000)
social change Social process whereby the values, attitudes, or institutions of society, such as education, family, religion, and industry become modified. It includes both the natural process and action programs initiated by members of the community.
(12 Dec 1998)
enthalpy change <chemistry> In a reaction, this is more or less equal to the difference between the energy put into breaking bonds and the enery gained from new bond formation.
(13 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • amount of change
    ¸¹Àº Àܵ·(µ¿Àü)
  • change
    º¯È­,±³È¯,º¯È­ÇÏ´Ù,±³È¯ÇÏ´Ù,Àܵ·,µ¿Àü
  • change hands
    ÁÖÀÎÀÌ ¹Ù²î´Ù
  • change
    ¹Ù²Ù´Ù;º¯È­½ÃŰ´Ù;º¯°æÇÏ´Ù;°íÄ¡´Ù;(¿ÊÀ»)...À¸·Î °¥¾Æ ÀÔ´Ù;(ħ´ëÀÇ)½ÃÆ®¸¦ °¥´Ù;(¾î¸°¾ÆÀÌÀÇ)±âÀú±Í¸¦ °¥´Ù;ȯÀüÇÏ´Ù;Àܵ·À¸·Î ¹Ù²Ù´Ù;(¼öÇ¥.¾îÀ½.ȯÀ»)Çö±ÝÀ¸·Î ¹Ù²Ù´Ù;±³È¯ÇÏ´Ù;(Àå¼Ò.ÀÔÀåµîÀ»)¹Ù²Ù´Ù;(Å»°ÍÀ»)°¥¾ÆÅ¸´Ù;¹Ù²ãŸ´Ù;º¯ÇÏ´Ù;¹Ù²î´Ù;º¯È­ÇÏ´Ù;(´Þ.Á¶¼öµîÀÌ)
  • change gear
    (ÀÚµ¿Â÷.±â°èÀÇ)º¯¼Ó±â ÀåÄ¡
  • change machine
    Àܵ· ±³È¯±â
  • change ringing
    (±³È¸ µîÀÇ)ÀüÁ¶ ¸íÁ¾(¹ý)(Á¾À» ¿©·¯°¡Áö À½»ö,ƯÈ÷ 4ºÐÀ½°è·Î ¿ï¸®±â)
  • change wheel
    Àüȯ Åé´Ï¹ÙÄû 
  • change-down
    (ÀÚµ¿Â÷µîÀÇ ±â¾î¸¦)Àú¼ÓÀ¸·Î ¹Ù²Ù±â
  • change-of-ends
    üÀÎÁöÄÚÆ®;ÄÚÆ®±³Ã¼
  • change-up
    üÀÎÁö¾÷(ŸÀÚÀÇ Å¸À̹ÖÀ» ¾î±ß³ª°Ô Çϱâ À§ÇØ ¼Ó±¸ °°Àº ¸ð¼ÇÀ¸·Î ´øÁö´Â ¿Ï±¸)
  • functional change
    ±â´É Àüȯ
  • gear change
    (ƯÈ÷ ÀÚµ¿Â÷ÀÇ)º¯¼Ó·¹¹ö;±â¾î Àüȯ ÀåÄ¡
  • grammatical change
    ¹®¹ýÀû º¯È­;º£¸£³ÊÀÇ ¹ýÄ¢
  • sea change
    ¹Ù´Ù(Á¶¼ö)¿¡ ÀÇÇÑ º¯È­;º¯È­;º¯¸ð
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á